Two Sigma Investments, LP Infla Rx N.V. Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
A detailed history of Two Sigma Investments, LP transactions in Infla Rx N.V. stock. As of the latest transaction made, Two Sigma Investments, LP holds 19,716 shares of IFRX stock, worth $37,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,716
Previous 24,013
17.89%
Holding current value
$37,066
Previous $36,000
36.11%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IFRX
# of Institutions
34Shares Held
13.6MCall Options Held
30.9KPut Options Held
2.1K-
Suvretta Capital Management, LLC New York, NY5.73MShares$10.8 Million0.59% of portfolio
-
683 Capital Management, LLC New York, NY2.07MShares$3.89 Million0.37% of portfolio
-
Morgan Stanley New York, NY2.04MShares$3.83 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL667KShares$1.25 Million0.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL638KShares$1.2 Million0.0% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $83.1M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...